Sunday, Sep 25, 2022 | Last Update : 07:06 PM IST

  Business   Economy  01 Feb 2017  Govt to frame new rules on medical devices to draw investments

Govt to frame new rules on medical devices to draw investments

PTI
Published : Feb 1, 2017, 1:44 pm IST
Updated : Feb 1, 2017, 1:45 pm IST

Currently, 100 per cent FDI is allowed under the automatic route in the medical devices sector.

India is the largest provider of generic drugs globally, with the Indian generics accounting for 20 per cent of global exports in terms of volume. (Representational Image)
 India is the largest provider of generic drugs globally, with the Indian generics accounting for 20 per cent of global exports in terms of volume. (Representational Image)

New Delhi: Government today said it will amend the Drugs and Cosmetics Rules to ensure availability of medicines at reasonable prices and also formulate new norms for the medical devices sector to bring in investments.

"We propose to amend the Drugs and Cosmetic Rules to ensure availability of drugs at reasonable prices to ensure use of generic medicines. "New rules regarding medical devices will be formulated. These rules will be internationally harmonised and attract investments into this sector. This will reduce the cost of such devices," Finance Minister Arun Jaitley said.

India is the largest provider of generic drugs globally, with the Indian generics accounting for 20 per cent of global exports in terms of volume. Medical devices include any instrument, apparatus, appliance, implant, material or other article, whether used alone or in combination, including the software intended by its manufacturer to be used specially for human beings or animals for one or more of the specific purposes. India has achieved an eminent global position in the pharmaceutical sector.

However, the same has not been replicated in the medical devices industry. Currently, 100 per cent FDI is allowed under the automatic route in the medical devices sector to encourage manufacturing of equipment.  

Tags: budget 2017, medical device, investment, arun jaitley